newsfilter
← Latest News
ACCESS Newswire·

Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch

  • Sibannac, Inc. (OTCID:SNNC) welcomes President Trump's executive order accelerating federal research into ibogaine, MDMA, psilocybin, & related compounds.
  • Industry analysts predict rapid expansion of psychedelic-assisted wellness tourism targeting veterans, law enforcement officers, & first responders with depression or PTSD.
  • Market models estimate the psychedelic-assisted wellness tourism sector could reach $5-$15 billion annually by 2030 driven by clinical development & regulatory clarity.
  • Veterans, law enforcement, & first responders could represent 10-25% of this market, generating $500 million to $3.75 billion in annual revenues by 2030.
  • Federal research acceleration is expected to shorten therapeutic protocol timelines & expand licensed clinic networks domestically & internationally.
  • CEO David Mersky states that rigorous federal research unlocks clinical & commercial pathways to scale compassionate care for trauma-related conditions.
  • Sibannac curates psychedelic & plant-medicine tours in the US & abroad for individuals seeking treatment for trauma or consciousness expansion.
  • The press release includes a cautionary note regarding forward-looking statements about financing plans, growth strategies, & potential risks affecting actual results.